Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Suda Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Suda blames Biotron comparisons on Twitter for 60pc share price spike
Health & Biotech
Rhinomed does US deal to put cannabis up your nose
News
Lunchtime ASX small cap wrap: who’s storming ahead today
Health & Biotech
Medlab’s cannabis mouth spray for cancer pain is a step closer after test results
Health & Biotech
Undervalued Suda due for a rise with Viagra spray
Health & Biotech
